| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1995;91:741-745.)
© 1995 American Heart Association, Inc.
Articles |
Do Patients With Primary Pulmonary Hypertension Develop Extensive Central Thrombi?
From the Pulmonary and Critical Care Division, Pulmonary Vascular Service, Department of Medicine, University of California, San Diego, School of Medicine (K.M.M., P.F.F.), and the Departments of Medicine and Pathology, University of California, San Francisco, School of Medicine (W.E.F., J.G.).
Correspondence to Kenneth M. Moser, MD, Pulmonary and Critical Care Division, University of California at San Diego, 225 Dickinson St, San Diego, CA 92103.
Background Distinguishing chronic major vessel thromboembolic pulmonary hypertension from primary pulmonary hypertension is critical because the treatment options differ markedly. Surgical thromboendarterectomy is potentially curative in the former condition, whereas oxygen, vasodilators, perhaps anticoagulation, and lung transplantation are the options for the latter. The development of large thrombi in the main, right, or left pulmonary arteries has not been previously described in patients with primary pulmonary hypertension.
Methods and Results Three pulmonary hypertensive patients with massive thrombi in the central pulmonary arteries are described. The data indicate that the large central thrombi in these three patients were not hemodynamically significant. In none did perfusion lung scans demonstrate segmental or larger defects.
Conclusions Large central thrombi can develop in patients with primary pulmonary hypertension. Perfusion lung scans that do not demonstrate segmental or larger defects should alert physicians to this possibility. Chest computed tomography and other studies identifying such thrombi are not adequate in distinguishing such a development from operable chronic major vessel thromboembolic hypertension. Careful review of lobar and segmental artery findings and the pulmonary angiogram, angioscopy, and cardiac catheterization data demonstrating the hemodynamic significance (or lack thereof) of these thrombi are essential in making this important distinction. Furthermore, these observations may constitute an additional indication for anticoagulant therapy in primary pulmonary hypertension.
Key Words: hypertension, pulmonary • thrombosis
This article has been cited by other articles:
 |
|
 |
|
  B. Degano, G. Prevot, L. Tetu, O. Sitbon, G. Simonneau, and M. Humbert Fatal dissection of the pulmonary artery in pulmonary arterial hypertension Eur. Respir. Rev., September 1, 2009; 18(113): 181 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Suntharalingam, R. D Machado, L. D Sharples, M. R Toshner, K. K Sheares, R. J Hughes, D. P Jenkins, R. C Trembath, N. W Morrell, and J. Pepke-Zaba Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertension Thorax, July 1, 2007; 62(7): 617 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hardziyenka, H. J. Reesink, B. J. Bouma, H.A.C.M. R. de Bruin-Bon, M. E. Campian, M. W.T. Tanck, R. B.A. van den Brink, J. J. Kloek, H. L. Tan, and P. Bresser A novel echocardiographic predictor of in-hospital mortality and mid-term haemodynamic improvement after pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension Eur. Heart J., April 1, 2007; 28(7): 842 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Johnson, S. Mehta, and J. T. Granton Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review. Eur. Respir. J., November 1, 2006; 28(5): 999 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ulrich, M. Fischler, R. Speich, V. Popov, and M. Maggiorini Chronic thromboembolic and pulmonary arterial hypertension share acute vasoreactivity properties. Chest, September 1, 2006; 130(3): 841 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Rubin, M. M. Hoeper, W. Klepetko, N. Galie, I. M. Lang, and G. Simonneau Current and Future Management of Chronic Thromboembolic Pulmonary Hypertension: From Diagnosis to Treatment Responses Proceedings of the ATS, September 1, 2006; 3(7): 601 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Peacock, G. Simonneau, and L. Rubin Controversies, Uncertainties and Future Research on the Treatment of Chronic Thromboembolic Pulmonary Hypertension Proceedings of the ATS, September 1, 2006; 3(7): 608 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Hoeper, E. Mayer, G. Simonneau, and L. J. Rubin Chronic Thromboembolic Pulmonary Hypertension Circulation, April 25, 2006; 113(16): 2011 - 2020. [Full Text] [PDF]
|
|
|
|
|
|
M. M. Hoeper, T. Kramm, H. Wilkens, C. Schulze, H. J. Schafers, T. Welte, and E. Mayer Bosentan Therapy for Inoperable Chronic Thromboembolic Pulmonary Hypertension Chest, October 1, 2005; 128(4): 2363 - 2367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Heinrich, M. Uder, D. Tscholl, A. Grgic, B. Kramann, and H.-J. Schafers CT Scan Findings in Chronic Thromboembolic Pulmonary Hypertension: Predictors of Hemodynamic Improvement After Pulmonary Thromboendarterectomy Chest, May 1, 2005; 127(5): 1606 - 1613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Remy-Jardin, A. Duhamel, V. Deken, N. Bouaziz, P. Dumont, and J. Remy Systemic Collateral Supply in Patients with Chronic Thromboembolic and Primary Pulmonary Hypertension: Assessment with Multi-Detector Row Helical CT Angiography Radiology, April 1, 2005; 235(1): 274 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Task Force members, N. Galie, A. Torbicki, R. Barst, P. Dartevelle, S. Haworth, T. Higenbottam, H. Olschewski, A. Peacock, G. Pietra, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology Eur. Heart J., December 2, 2004; 25(24): 2243 - 2278. [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Fedullo, W. R. Auger, K. M. Kerr, and L. J. Rubin Chronic Thromboembolic Pulmonary Hypertension N. Engl. J. Med., November 15, 2001; 345(20): 1465 - 1472. [Full Text] [PDF]
|
|
|
|
 |
|
 P Pruszczyk, A Torbicki, A Kuch-Wocial, M Szulc, and R Pacho Diagnostic value of transoesophageal echocardiography in suspected haemodynamically significant pulmonary embolism Heart, June 1, 2001; 85(6): 628 - 634. [Abstract] [Full Text]
|
|
|
|
|
|
N. Galiè and A. Torbicki GENERAL CARDIOLOGY: Pulmonary arterial hypertension: new ideas and perspectives Heart, April 1, 2001; 85(4): 475 - 480. [Full Text]
|
|
|
|
|
|
J. Lewczuk, P. Piszko, J. Jagas, A. Porada, S. Wojciak, B. Sobkowicz, and K. Wrabec Prognostic Factors in Medically Treated Patients With Chronic Pulmonary Embolism Chest, March 1, 2001; 119(3): 818 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Galie Do we need controlled clinical trials in pulmonary arterial hypertension? Eur. Respir. J., January 1, 2001; 17(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Frazier, J. R. Galvin, T. J. Franks, and M. L. Rosado-de-Christenson From the Archives of the AFIP : Pulmonary Vasculature: Hypertension and Infarction (CME available in print version and on RSNA Link) RadioGraphics, March 1, 2000; 20(2): 491 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mo, D. P. Kapelanski, S. N. Mitruka, W. R. Auger, P. F. Fedullo, R. N. Channick, K. Kerr, C. Archibald, and S. W. Jamieson Reoperative pulmonary thromboendarterectomy Ann. Thorac. Surg., November 1, 1999; 68(5): 1770 - 1776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Russo, M. De Luca, C. Vigna, Vincenzo De Rito, M. Pacilli, A. Lombardo, M. Armillotta, R. Fanelli, and F. Loperfido Central Pulmonary Artery Lesions in Chronic Obstructive Pulmonary Disease : A Transesophageal Echocardiography Study Circulation, October 26, 1999; 100(17): 1808 - 1815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Pitton, C. Duber, E. Mayer, and M. Thelen Hemodynamic Effects of Nonionic Contrast Bolus Injection and Oxygen Inhalation During Pulmonary Angiography in Patients With Chronic Major-Vessel Thromboembolic Pulmonary Hypertension Circulation, November 15, 1996; 94(10): 2485 - 2491. [Abstract] [Full Text]
|
|